Clinical trials are crucial for advancing medical breakthroughs and testing new treatments that may become tomorrow’s cures. At WashU Medicine/Barnes Jewish Hospital, research on acute treatment, recovery and rehabilitation and stroke prevention is fundamental to the mission of stroke research. Insights gained from these clinical trials are vital for enhancing patient health outcomes following a stroke and helping patients regain their pre-stroke quality of life.
How to participate
What is a clinical trial? Clinical trials are research studies that test a medical, surgical, or behavioral intervention in people. Information learned from clinical trials will help patients live longer, healthier lives. Clinical studies are carefully and ethically designed to protect participants from unnecessary side effects and other risks.
Contact Jenny Babka with the Stroke Patient Access Core (SPAC) at 314-747-8794 if you are interested in participating in one of our ongoing stroke clinical trials.
Featured clinical trials
We are one of 29 regional coordinating centers and are ranked fourth in total enrollments across StrokeNet since our inception in 2018. Our stroke clinical trials focus on acute treatment, recovery, rehabilitation and stroke prevention.
- Conditions: Intracranial Arteriosclerosis; Stroke Interventions: Drug: Ticagrelor + Aspirin; Drug: Rivaroxaban + Aspirin; Drug: Clopidogrel + Aspirin; Other: Risk Factor Management Sponsors: University of Florida; National Institute of Neurological Disorders and Stroke (NINDS); University of Cincinnati; Medical University of South Carolina; Janssen Scientific Affairs, LLC; AstraZeneca Recruiting
- Conditions: Ischemic Stroke; Sleep Apnea; Sleep Apnea, Obstructive; Stroke; CPAP; Telemedicine; Home Sleep Apnea Test; Randomized Clinical Trial; Multicenter Trial Interventions: Device: CPAP Sponsors: University of Michigan; National Institute of Neurological Disorders and Stroke (NINDS); FusionHealth LLC; Medical University of South Carolina; University of Cincinnati Recruiting
- Conditions: Ischemic Stroke Interventions: Biological: TS23 Sponsors: Translational Sciences, Inc.; University of Cincinnati; National Institute of Neurological Disorders and Stroke (NINDS); Medical University of South Carolina; University of Arizona Recruiting
- Conditions: Intracerebral Hemorrhage Interventions: Biological: Recombinant Activated Factor VII (rFVIIa); Biological: Placebo Sponsors: Joseph Broderick, MD; Novo Nordisk A/S; National Institute of Neurological Disorders and Stroke (NINDS) Recruiting
- Conditions: Intracerebral Hemorrhage; Atrial Fibrillation Interventions: Drug: Apixaban; Drug: Aspirin Sponsors: Yale University; National Institute of Neurological Disorders and Stroke (NINDS) Recruiting
- Conditions: Ischemic Stroke Interventions: Device: Endovascular thrombectomy with any FDA-approved category POL or NRY device; Other: Medical Management Sponsors: Medical University of South Carolina; National Institute of Neurological Disorders and Stroke (NINDS); University of Cincinnati; University of Virginia; Berry Consultants; University of California, Los Angeles; MOUNT SINAI HOSPITAL; The Cooper Health System; University of Pittsburgh Medical Center; Stony Brook University; University at Buffalo Recruiting
- Conditions: Perinatal Stroke; Hemiparesis Interventions: Behavioral: I-ACQUIRE – High Dosage; Behavioral: I-ACQUIRE – Moderate Dosage; Behavioral: Usual & Customary Treatment (U&CT) Sponsors: Virginia Polytechnic Institute and State University; Ohio State University; Nationwide Children's Hospital; Stanford University; University of Cincinnati; Medical University of South Carolina Active, not recruiting
- Conditions: Pediatric Stroke; Arteriopathy; Arterial Ischemic Stroke Interventions: Drug: methylprednisolone, prednisolone, prednisone Sponsors: University of California, San Francisco; University of Cincinnati; Medical University of South Carolina; M.D. Anderson Cancer Center; University of Colorado, Denver; University of Iowa; National Institute of Neurological Disorders and Stroke (NINDS); American Heart Association Enrolling by invitation
- Conditions: Intracerebral Hemorrhage Interventions: Drug: Statins Sponsors: Beth Israel Deaconess Medical Center; NINDS Stroke Trials Network (StrokeNet); Canadian Stroke Consortium (CSC); University of Cincinnati; Medical University of South Carolina; Yale University; MetroHealth Medical Center; UH, Cleveland Medical Center; Spectrum Health Hospitals; West Virginia University; Columbia University; Weill Medical College of Cornell University; New York Presbyterian Brooklyn Methodist Hospital; Buffalo General Medical Center; State University of New York – Upstate Medical University; St. Joseph's Regional Medical Center, New Jersey; Tufts Medical Center; Massachusetts General Hospital; UMASS Memorial Medical Center; Brigham and Women's Hospital; Baystate Medical Center; University of Vermont Medical Center; […]